Cargando…
Potential Protein Biomarkers for Preeclampsia
To date, the etiology of preeclampsia (PE) has not been clarified and the specific treatment is lacking; hence, early prediction and prevention are very important. Thus, a large number of biomarkers that may be associated with PE have been identified based on proteomics to provide a reference for th...
Autores principales: | He, Andong, Zhou, Yixuan, Wei, Yiling, Li, Ruiman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7336689/ https://www.ncbi.nlm.nih.gov/pubmed/32642389 http://dx.doi.org/10.7759/cureus.8925 |
Ejemplares similares
-
Cysteinyl Leukotriene and Systemic Inflammatory Levels in Preeclampsia
por: Guzeltas, Gokhan, et al.
Publicado: (2023) -
An Evaluation of T-Regulatory Cells and Inflammatory Cytokines in Preeclampsia
por: Koppisetty, Bharath Kumar, et al.
Publicado: (2023) -
Is There a Predictable Cost-Benefit Ratio in Preeclampsia?
por: Ozkan, Dogukan, et al.
Publicado: (2023) -
Antiphospholipid Syndrome and Preeclampsia in Pregnancy: A Case Report
por: Skoura, Rafailia, et al.
Publicado: (2022) -
Is the First-Trimester Systemic Immune-Inflammation Index Associated With Preeclampsia?
por: Cevher Akdulum, Munire Funda, et al.
Publicado: (2023)